PER® Postgame: Breaking Down the Latest Data and Updates in Anemia of Chronic Kidney Disease – Fall 2021 Nephrology Meeting Takeaways

Target Audience
This educational activity is directed toward nephrologists and primary care physicians. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of CKD and anemia are also invited to attend.

Program Overview
Chronic kidney disease (CKD) is associated with a markedly higher risk of anemia, and this CKD-associated anemia is linked, in turn, to lower quality of life and increased morbidity and mortality. Despite conventional treatments for CKD-related anemia, unmet needs remain in the optimal management of this complication.

This program will feature experts from primary care and nephrology, who will discuss emerging targets in the pathophysiology of anemia in CKD, opportunities for improved diagnosis and management of CKD-related anemia in primary care and nephrology settings, and fresh data on a novel class of investigational agents—all in a lively new format.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Review the clinical burden of anemia in patients with CKD
Discuss the pathophysiology of anemia in CKD, including therapeutic targets
Apply current assessment strategies to accurately diagnose patients with anemia and CKD based on clinical presentation
Describe safety and efficacy data on new and emerging agents for patients with CKD-associated anemia